The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection

Hyun Su Ri1, Sang Wook Shin, Tae Kyun Kim

  • 1Department of Anesthesiology and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea.

Abstract

Insights

Remifentanil pretreatment effectively prevents etomidate-induced myoclonus during anesthesia induction. A 2 ng/ml concentration significantly reduced myoclonus incidence without causing adverse effects like bradycardia or hypotension.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Etomidate bolus injection commonly causes myoclonus during anesthetic induction, posing challenges for anesthesiologists.
  • Investigating optimal remifentanil dosing is crucial for mitigating this side effect.

Purpose of the Study:

  • To determine the effective dose of remifentanil for preventing etomidate-induced myoclonus.
  • To assess the safety profile of remifentanil pretreatment at varying concentrations.

Main Methods:

  • Patients (ASA I-III) received etomidate (0.3 mg/kg) for induction.
  • Three groups were pretreated with remifentanil via target-controlled infusion (TCI) at effect-site concentrations of 0, 2, or 4 ng/ml.
  • Myoclonus incidence and side effects were monitored.

Main Results:

  • Myoclonus incidence was significantly reduced with remifentanil pretreatment (81% in control vs. 12% at 2 ng/ml and 0% at 4 ng/ml).
  • No significant bradycardia or hypotension occurred in the 2 ng/ml or 4 ng/ml groups.
  • Chest wall rigidity was observed in 45% of patients in the 4 ng/ml group.

Conclusions:

  • A 2 ng/ml effect-site concentration of remifentanil effectively reduces etomidate-induced myoclonus.
  • This dose prevents myoclonus without significant adverse cardiovascular effects or chest wall rigidity.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...